If you have been reading about RP-HPLC and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-10-11. Numbers and descriptions here follow the published literature rather than marketing material.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.
Identity and purity are assessed with a small set of standard peptide methods. Reversed-phase high-performance liquid chromatography separates the main peak from truncated or oxidized species, and its area percentage is the usual purity measure. Mass spectrometry confirms the observed molecular mass against the expected value, while amino acid analysis or peptide mapping checks composition and sequence. Specifications for research-grade material are often stated as 95 percent or higher, though the exact limit depends on the supplier and the intended use.
Laboratory supplies of the peptide usually arrive as a lyophilized powder in sealed vials. The powder is hygroscopic, so a vial should be allowed to reach room temperature before it is opened to prevent condensation on the contents. Weighing and transfer are best performed in a low-humidity environment with clean tools. Once dissolved, the solution should be mixed gently rather than vortexed, because foaming and shear can reduce recovery of the peptide.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Peptide | 28 amino acid residues |
| Molecular weight | Approximately 3108 Da | Depends on acetylation state |
| N-terminal modification | Acetylated | Affects charge and stability |
| Natural source | Fragment of thymosin beta-4 | Cleaved in vivo |
| Sequence length | 28 residues | Synthetic form matches natural |
The peptide was identified during work in the 1970s on thymosin fraction 5, a partially purified extract of calf thymus. Investigators separated that mixture and characterized individual components, one of which they named thymosin alpha-1. The same compound later received the international nonproprietary name thymalfasin. Commercial material is produced by solid-phase peptide synthesis rather than by extraction, so synthetic and natural forms share an identical sequence. Naming conventions vary across the literature, and readers should distinguish the alpha-1 peptide from other thymosins that have unrelated sequences and functions.
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
Thymosin alpha-1 is a synthetic peptide of 28 amino acid residues that corresponds to a naturally occurring fragment first isolated from thymus tissue. Its chain is acetylated at the amino terminus, a modification that shields the peptide from rapid cleavage by aminopeptidases. The molecule carries a net negative charge at physiological pH and dissolves freely in water. Researchers classify it as an immune-modulating agent rather than a classical hormone, because it acts on several cell types of both the innate and the adaptive immune system.
Quality control for thymosin alpha-1 focuses on identity, purity, and potency. Identity is confirmed by mass spectrometry and amino acid analysis, while purity is assessed by chromatography with limits on related substances and residual solvents. Potency assays may use cell-based immune readouts, but these are not standardized across laboratories. Regulatory status differs by jurisdiction; no product is approved in the United States for clinical use, whereas some other countries register injectable forms for specific indications.
Quantifying thymosin alpha-1 in a sample usually relies on reverse-phase high-performance liquid chromatography. The peptide lacks strong chromophores, so detection often occurs at 214 nm, where the peptide backbone absorbs. Mass spectrometry provides confirmatory identification and can detect sequence variants or truncations. Immunoassays have been used in biological matrices, but they may cross-react with related fragments. For purity assessment, chromatographic peak area gives the main component percentage, while mass accuracy verifies molecular identity.
=== Digestion === Amino acids that move beyond the terminal ileum in the body are less likely to be absorbed for use in protein synthesis. They may pass out of the body or become absorbed by bacteria, thus appearing to have been digested instead of being present in the feces. The PDCAAS takes no account of where the proteins have been digested. Similarly, amino acids that are lost due to antinutritional factors present in many foods are assumed to be digested according to the PDCAAS. This is linked with the earlier problem, as an antinutritional factor may prevent the rat's small intestines from absorbing the protein but do not deter the rat's gut bacteria from doing so. In addition, older rats show lower PDCAAS-estimated fecal digestibility compared to young rats when the protein source contains antinutritional factors. The report of 1989 did make use of existing per-amino-acid ileum digestibility values, but the requirement of pumping material out of the ileum was seen as too cumbersome. The fecal digestibility of the entire protein was adopted as a convenient approximation. It was found to be within 10% of the true amino-acid digestibility when applied to most protein sources with the notable exception of grain legumes. With beans, peas and lentils, the true digestibility of methionine, cystine and tryptophan can be much lower. In 2013, the FAO proposed changing to Digestible Indispensable Amino Acid Score, which uses per-amino-acid ileum digestibility.
=== Secondary standards === Secondary standards do not satisfy the requirements for a primary standard. A standard solution created from a secondary standard cannot have its concentration accurately known without stoichiometric analysis against a primary standard. An example of a secondary standard is sodium hydroxide, a hydroscopic compound that is highly reactive with its surroundings. The concentration of a standard solution made with sodium hydroxide may fluctuate over time due to the instability of the compound, requiring for calibration using a primary standard before use.
(registration required) Shahid, I. (2000). "Tanūkh". In Bearman, P. J.; Bianquis, Th.; Bosworth, C. E.; van Donzel, E. & Heinrichs, W. P. (eds.). The Encyclopaedia of Islam, Second Edition. Volume X: T–U. Leiden: E. J. Brill. pp. 190–192. ISBN 978-90-04-11211-7. Sourdel, D. (1971). "Ḥawrān". In Lewis, B.; Ménage, V.L.; Pellat, Ch.; Schacht, J. (eds.). The Encyclopaedia of Islam, New Edition. Vol. III: H–Iram. Leiden: E.J. Brill. pp. 292–293. ISBN 90-04-08118-6. Stone, Christopher (2008). Popular Culture and Nationalism in Lebanon: The Fairouz and Rahbani Nation. Abingdon, Oxon and New York: Routledge. ISBN 978-0-415-77273-0.
== Prevention == Cara Myer, the author of "The Tea and Toast Syndrome: Psychosocial Aspects of Congregate Dining" suggests that congregate dining for older adults may be an excellent strategy to prevent tea and toast syndrome. Myer mentions that social service interventions for malnutrition, including congregate dining, are often under-utilized and could provide a stimulating environment that may improve the quality of life of many older adults. Further, general preventative measures focus on evaluating the nutrition of older adults, including keeping a record of weight patterns, helping with meal plans focusing on nutrient-rich foods, and using local services such as a meal delivery program. Additional strategies include:
The four substrates of this enzyme are (−)-menthol, reduced nicotinamide adenine dinucleotide phosphate (NADPH), oxygen, and a proton. Its products are p-menthane-3,8-diol, oxidised NADP+, and water. This enzyme is an oxidoreductase, acting on paired donors, with molecular oxygen as oxidant and incorporating one of its atoms. The systematic name of this enzyme class is (−)-menthol,NADPH:oxygen oxidoreductase (8-hydroxylating). This enzyme is also called l-menthol monooxygenase.
Sources: en.wikipedia.org
== Regulation == Protein concentration, which in turn are affected by expression levels and degradation rates; Protein affinity for proteins or other binding ligands; Ligands concentrations (substrates, ions, etc.); Presence of other proteins, nucleic acids, and ions; Electric fields around proteins. Occurrence of covalent modifications;
4 Cytc2+ + O2 + 8H+inside → 4 Cytc3+ + 2 H2O + 4H+outside Although the heme proteins are the most important class of iron-containing proteins, the iron–sulfur proteins are also very important, being involved in electron transfer, which is possible since iron can exist stably in either the +2 or +3 oxidation states. These have one, two, four, or eight iron atoms that are each approximately tetrahedrally coordinated to four sulfur atoms; because of this tetrahedral coordination, they always have high-spin iron. The simplest of such compounds is rubredoxin, which has only one iron atom coordinated to four sulfur atoms from cysteine residues in the surrounding peptide chains. Another important class of iron–sulfur proteins is the ferredoxins, which have multiple iron atoms. Transferrin does not belong to either of these classes. The ability of sea mussels to maintain their grip on rocks in the ocean is facilitated by their use of organometallic iron-based bonds in their protein-rich cuticles. Based on synthetic replicas, the presence of iron in these structures increased elastic modulus 770 times, tensile strength 58 times, and toughness 92 times. The amount of stress required to permanently damage them increased 76 times.
Total population of the FR Yugoslavia – 10,019,657 Serbia (total): 9,396,411 Vojvodina: 2,116,725 Central Serbia: 5,479,686 Kosovo: 1,800,000 Montenegro: 623,246 Major cities (over 100,000 inhabitants) – 2002 data (2003 for Podgorica): Beograd (Belgrade): 1,280,639 (1,574,050 metro) Novi Sad: 215,600 (298,139 metro) Pristina: 200,000 (2002 estimate) Niš: 173,390 (234,863 metro) Kragujevac: 145,890 (175,182 metro) Podgorica: 139,500 (169,000 metro) Prizren: 121,000 (2002 estimate) Subotica: 99,471 (147,758 metro) More than half of Kosovo's pre-1999 Serb population (226,000), including 37,000 Romani, 15,000 Balkan Muslims (including Ashkali, Bosniaks, and Gorani), and 7,000 other non-Albanian civilians were expelled to central Serbia and Montenegro, following the Kosovo War. According to a 2004 estimate, the State Union had 10,825,900 inhabitants. According to a July 2006 estimate, the State Union had 10,832,545 inhabitants.
Clinical identification of P. aeruginosa may include identifying the production of both pyocyanin and fluorescein, as well as its ability to grow at 42 °C. P. aeruginosa is capable of growth in diesel and jet fuels, where it is known as a hydrocarbon-using microorganism, causing microbial corrosion. It creates dark, gellish mats sometimes improperly called "algae" because of their appearance.
Sources: en.wikipedia.org
It corresponds to the first 28 amino acids of thymosin beta-4, a larger protein found in many tissues. The fragment is acetylated at its N-terminus and is produced synthetically for research and pharmaceutical use. Synthetic and natural forms share the same sequence.
It is usually described as an immunomodulatory peptide rather than a classical hormone. It does not travel to a single distant organ in the manner of an endocrine hormone. Classification varies across sources, and some texts group it with thymic peptides generally.
The broad outline involves immune cell activation, but the specific molecular steps remain under investigation. Different studies report effects on dendritic cells, T cells, and natural killer cells. No single receptor has been confirmed as the sole mediator.
Aliquots are typically frozen well below zero Celsius and thawed only once, since repeated cycles promote aggregation and loss. Dilution into a neutral buffer limits degradation during short working periods, and prolonged storage at room temperature is avoided.